These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25839711)

  • 1. Chemokines in the melanoma metastasis biomarkers portrait.
    Neagu M; Constantin C; Longo C
    J Immunoassay Immunochem; 2015; 36(6):559-66. PubMed ID: 25839711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
    McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
    Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status.
    Mitchell B; Leone D; Feller JK; Bondzie P; Yang S; Park HY; Mahalingam M
    Melanoma Res; 2014 Dec; 24(6):621-5. PubMed ID: 25211166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
    Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
    Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma.
    Mitchell B; Mahalingam M
    Histol Histopathol; 2014 Dec; 29(12):1539-46. PubMed ID: 24879309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility?
    Mitchell B; Leone D; Feller K; Menon S; Bondzie P; Yang S; Park HY; Mahalingam M
    Hum Pathol; 2014 Oct; 45(10):2094-100. PubMed ID: 25130395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Metastasis of BRAF+ Cutaneous Malignant Melanoma.
    Gonzalez A; Miles JF; Khurshid GS
    Ophthalmol Retina; 2018 Jan; 2(1):71. PubMed ID: 31047306
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
    Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
    Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway?
    Motlak M; Mathews M; Al-Odat OS; Pandey MK
    Cytokine; 2024 Jul; 179():156629. PubMed ID: 38704961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.
    Hofman V; Ilie M; Long-Mira E; Giacchero D; Butori C; Dadone B; Selva E; Tanga V; Passeron T; Poissonnet G; Emile JF; Lacour JP; Bahadoran P; Hofman P
    J Invest Dermatol; 2013 May; 133(5):1378-81. PubMed ID: 23303445
    [No Abstract]   [Full Text] [Related]  

  • 12. A Case of Giant Primary Dermal Melanoma with BRAF V600E Mutation.
    Imamura T; Nakamura Y; Teramoto Y; Sato S; Asami Y; Arai E; Yamamoto A
    Acta Derm Venereol; 2016 Aug; 96(6):840-1. PubMed ID: 26984828
    [No Abstract]   [Full Text] [Related]  

  • 13. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Map3k1 Loss Cooperates with Braf
    Trucco LD; Mundra PA; García-Martínez P; Hogan K; Baenke F; Dhomen N; Pavet V; Marais R
    J Invest Dermatol; 2021 Jan; 141(1):221-225.e6. PubMed ID: 32450073
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
    Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
    Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
    Pocza P; Süli-Vargha H; Darvas Z; Falus A
    Int J Cancer; 2008 May; 122(9):1972-80. PubMed ID: 18076073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific prognostic biomarkers in melanoma.
    Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y
    Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.
    Monteagudo C; Ramos D; Pellín-Carcelén A; Gil R; Callaghan RC; Martín JM; Alonso V; Murgui A; Navarro L; Calabuig S; López-Guerrero JA; Jordá E; Pellín A
    Clin Exp Metastasis; 2012 Aug; 29(6):625-37. PubMed ID: 22526457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and
    García-Silva S; Benito-Martín A; Sánchez-Redondo S; Hernández-Barranco A; Ximénez-Embún P; Nogués L; Mazariegos MS; Brinkmann K; Amor López A; Meyer L; Rodríguez C; García-Martín C; Boskovic J; Letón R; Montero C; Robledo M; Santambrogio L; Sue Brady M; Szumera-Ciećkiewicz A; Kalinowska I; Skog J; Noerholm M; Muñoz J; Ortiz-Romero PL; Ruano Y; Rodríguez-Peralto JL; Rutkowski P; Peinado H
    J Exp Med; 2019 May; 216(5):1061-1070. PubMed ID: 30975894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
    Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
    Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.